FIND A CLINICAL TRIAL
Every advancement in curing childhood cancer is the result of research.
At the Aflac Cancer and Blood Disorders Center, we are committed to excellence and innovation in pediatric cancer and blood disorders research. Our rapidly growing research program includes physicians and Ph.D.s in the following fields of study: BMT, brain tumors, cancer survivorship, leukemia/lymphoma, solid tumors, hemostasis/thrombosis, sickle cell disease, gene therapy and transfusion medicine.
At the Aflac Cancer Center, there is a significant opportunity to advance research and teaching in pediatric hematology/oncology. We are uniquely positioned to leverage the vast capabilities in Atlanta through collaborative relationships with:
- Emory University School of Medicine
- Emory Winship Cancer Institute
- Emory University’s Rollins School of Public Health
- Georgia Institute of Technology
- Centers for Disease Control and Prevention (CDC)
Additionally, our physicians participate and often play leadership roles in all of the major national collaborative research consortia geared towards the early clinical development of promising therapies for the treatment of cancer and blood disorders, including:
- Children’s Oncology Group, including the Phase I and Pilot Consortium
- New Approaches to Neuroblastoma Therapy (NANT)
- Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL)
- Pediatric Blood and Marrow Transplant Consortium (PBMTC)
- Transfusion Medicine and Hemostasis Research Network through the NIH
- Sickle Cell Clinical Research Network through the NIH